Skip to content

A prospective study on the effects of cysteine peptide-containing yeast-derived supplement on healthy feeling, skin quality and blood glutathione levels

A prospective study on the effects of cysteine peptide-containing yeast-derived supplement on healthy feeling, skin quality and blood glutathione levels

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030240357
Enrollment
30
Registered
2024-09-29
Start date
2024-09-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Improvement of skin quality

Interventions

Taking yeast supplements containing cysteine peptides:Take 6 tablets (containing approximately 96 mg of cysteine peptide) once a day after breakfast for 12 weeks

Sponsors

Nishizaki Yasuhiro
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: *Gender: Male, Female *Age: 40 years old or older, under 60 years old *Those who return the reply postcard by October 31, 2024

Exclusion criteria

Exclusion criteria: *Those currently undergoing medication or outpatient treatment for any serious illness. *Those who are taking or using anti-inflammatory drugs for the skin (topical and oral) at least once a month on an ongoing basis. *Those who have difficulty reporting topical preparations or foods (ingredients: glutathione, cysteine, astaxanthin, coenzyme Q10, etc.) such as medicines, quasi-drugs, cosmetics, health foods, and supplements that claim or emphasize whitening effects, sunburn prevention effects, or skin quality improvement effects (prevention/improvement of spots, prevention/improvement of rough skin, cell turnover promotion effects).

Design outcomes

Primary

MeasureTime frame
Plasma glutathione: total glutathione, GSH, GSSG

Secondary

MeasureTime frame
Yeast supplement research questionnaire, Anti-aging QOL common questionnaire, Skin condition

Contacts

Public ContactYasuhiro Nishizaki

Tokai University School of Medicine

y-nishizaki@tokai.ac.jp+81-463-93-2321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026